BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Black Cardiologists - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abcardio.org
X-WR-CALDESC:Events for Association of Black Cardiologists
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251004T090000
DTEND;TZID=America/New_York:20251004T163000
DTSTAMP:20260619T091051
CREATED:20250708T170536Z
LAST-MODIFIED:20250708T184634Z
UID:2553-1759568400-1759595400@abcardio.org
SUMMARY:Conversations in Cardiology: 2025 - Live Virtual Conference
DESCRIPTION:Join us online for this live virtual broadcast and stay on track to fulfill your CME/CE requirements from the comfort of your home. \nWith rapid changes in medicine\, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice. \nUtilizing an interactive\, moderator-led format\, this program will present discussions with national thought leaders\, who as clinicians themselves\, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science\, current treatment guidelines\, discuss challenging cases\, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning. \nLearning Objectives\nUpon completion of each of the lectures listed below\, learners should be able to: \nAn Expanding Armamentarium for Cardiac Amyloidosis \n\nIdentify patients with history\, symptoms\, or signs suggestive of ATTR who should be evaluated\nDiagnose ATTR-CM by applying current guidelines and literature updates to patients’ diagnostic workup\nDiscuss the evolving landscape of approved and emerging disease-directed treatments for ATTR-CM\nIndividualize the management of patients with ATTR-CM\, considering ongoing monitoring and pharmacotherapy for HF and cardiac amyloidosis\n\nThe HFpEF & HFmrEF Puzzle: Closing the Treatment Gaps \n\nRecognize the residual risk associated with real-world utilization of standard treatments for patients with HFmrEF and HFpEF\nDiscuss recent clinical data on non-steroidal MRAs in the management of HFmrEF and HFpEF\nOptimize the management of HFmrEF and HFpEF based on patient comorbidities\, current guidelines\, and evolving data\n\nUncontrolled T2D\, Hypertension\, and Cortisol: Connecting the Dots \n\nRecognize the increased prevalence of hypercortisolism in patients with T2D and/or resistant hypertension\nImplement appropriate screening and diagnostic testing for hypercortisolism in patients with difficult-to-treat T2D and/or resistant hypertension\nReview emerging data on current and novel agents to address identifiable and non-identifiable sources of hypercortisolism\nIndividualize the management of patients with Cushing’s syndrome based on cortisol source\, comorbidities\, and patient preferences\n\nCoordinated Efforts – When Statin Alone Isn’t Enough \n\nIdentify patients with elevated ASCVD risk based on history\, laboratory findings\, and comorbidities\nIntegrate evolving clinical data and guideline recommendations to optimize LDL lowering in patients with established ASCVD or at high risk for cardiovascular diseases (CVD)\n\n 
URL:https://abcardio.org/event/conversations-in-cardiology-2025-live-virtual-conference/
ATTACH;FMTTYPE=image/jpeg:https://abcardio.org/wp-content/uploads/2025/07/heart.jpg
END:VEVENT
END:VCALENDAR